Cargando…

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies

Detalles Bibliográficos
Autores principales:	Morrison, Brett, Hensley, Kenneth, Pioro, Erik P., Petri, Susanne, Kiaei, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536360/ https://www.ncbi.nlm.nih.gov/pubmed/23316357 http://dx.doi.org/10.1155/2012/798028

Ejemplares similares

Peroxisome Proliferator-Activated Receptor-γ in Amyotrophic Lateral Sclerosis and Huntington's Disease
por: Kiaei, Mahmoud
Publicado: (2008)

Mutant Profilin1 Aggregation in Amyotrophic Lateral Sclerosis: An in Vivo Biochemical Analysis
por: Nekouei, Mina, et al.
Publicado: (2021)

Progress in Therapy Development for Amyotrophic Lateral Sclerosis
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration
por: Ganne, Akshatha, et al.
Publicado: (2023)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Erratum to “Progress in Therapy Development for Amyotrophic Lateral Sclerosis”
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012)

Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
por: Kollewe, Katja, et al.
Publicado: (2012)

Molecular Research on Amyotrophic Lateral Sclerosis
por: Agnello, Luisa, et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis: Advances and Prospects
por: Boentert, Matthias, et al.
Publicado: (2023)

In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis
por: Sadr, Ahmad Shahir, et al.
Publicado: (2021)

Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
por: Bowerman, Melissa, et al.
Publicado: (2013)

Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
por: Yang, Xiaoming, et al.
Publicado: (2021)

Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation
por: Panchabhai, Tanmay S., et al.
Publicado: (2019)

Effects of Physical Activity on Amyotrophic Lateral Sclerosis
por: Maugeri, Grazia, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis as a Systemic Disease
por: Moresi, Viviana
Publicado: (2023)

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
por: Kollewe, Katja, et al.
Publicado: (2015)

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)

A Computational Study of Executive Dysfunction in Amyotrophic Lateral Sclerosis
por: Steinke, Alexander, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment
por: Tao, Qing-Qing, et al.
Publicado: (2017)

Diagnostic track in amyotrophic lateral sclerosis: the Brazilian experience
por: de Carvalho, Mamede
Publicado: (2022)

Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany
por: Schönfelder, Erik, et al.
Publicado: (2020)

Brain White Matter Shape Changes in Amyotrophic Lateral Sclerosis (ALS): A Fractal Dimension Study
por: Rajagopalan, Venkateswaran, et al.
Publicado: (2013)

Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: McCluskey, Gavin, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Frontotemporal Dementia in Amyotrophic Lateral Sclerosis: From Rarity to Reality?
por: Orsini, Marco, et al.
Publicado: (2016)

Amyotrophic Lateral Sclerosis - Cell Based Therapy and Novel Therapeutic Development
por: Kim, Changsung, et al.
Publicado: (2014)

Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
por: Webster, Christopher P., et al.
Publicado: (2017)

Decoding Amyotrophic Lateral Sclerosis: Discovery of Novel Disease-Related Biomarkers and Future Perspectives in Neurodegeneration
por: Calvo, Ana Cristina, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis Risk, Family Income, and Fish Consumption Estimates of Mercury and Omega-3 PUFAs in the United States
por: Hoffman, Hannah I., et al.
Publicado: (2021)

Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis
por: Loewe, Kristian, et al.
Publicado: (2017)

Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis
por: Seer, Caroline, et al.
Publicado: (2015)

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis
por: Green, Jordan R., et al.
Publicado: (2018)

Diets for Patients with Amyotrophic Lateral Sclerosis: Pay Attention to Nutritional Intervention
por: Yang, Li-Peng, et al.
Publicado: (2017)

Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
por: Shefner, Jeremy, et al.
Publicado: (2019)

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017)

Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
por: Amin, Azin, et al.
Publicado: (2020)

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
por: Proaño, Belén, et al.
Publicado: (2022)

Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
por: Körner, Sonja, et al.
Publicado: (2013)

Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies
por: Hemerková, Pavlína, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5b8u0u80ng0oppc9o34t06i39r